Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Cryo-Cell International Inc. (CCEL) had Revenue of $7.83M for the most recently reported fiscal quarter, ending 2025-08-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-08-31

Income Statement Financials
Revenue	$7.83M
Net Income	$0.75M
Cost of Goods Sold	$1.80M
Gross Profit	$6.02M
Operating Expenses	$5.92M
Operating Income	$1.90M
Non-Operating Income/Expense	$-0.71M
Pre-Tax Income	$1.19M
Normalized Pre-Tax Income	$1.38M
Income after Taxes	$0.75M
Income from Continuous Operations	$0.75M
Consolidated Net Income/Loss	$0.75M
Normalized Income after Taxes	$1.01M
EBIT	$1.90M
EBITDA	$2.26M
Weighted-Average Shares Outstanding (Basic)	8.06M
Weighted-Average Shares Outstanding (Diluted)	8.07M
Earnings per Share (EPS) (Basic)	$0.09
Earnings per Share (EPS) (Diluted)	$0.09
Balance Sheet Financials
Current Assets	$11.67M
Property, Plant, and Equipment	$21.20M
Long-Term Assets	$51.50M
Total Assets	$63.17M
Current Liabilities	$18.45M
Long-Term Debt	$8.21M
Long-Term Liabilities	$59.55M
Total Liabilities	$78.00M
Common Equity	$-14.83M
Tangible Shareholders Equity	$-17.65M
Shareholders Equity	$-14.83M
Common Shares Outstanding	8.05M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$4.20M
Cash Flow from Investing Activities	$-0.69M
Cash Flow from Financial Activities	$-3.81M
Beginning Cash	$0.56M
End Cash	$0.27M
Increase/Decrease in Cash	$-0.30M
Stock-Based Compensation	--
Common Stock Dividends Paid	$-3.23M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.63
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	-1.24
Debt to Equity Ratio	-0.78
Gross Margin	76.98%
Operating Margin	24.29%
EBIT Margin	24.29%
EBITDA Margin	--
Pre-Tax Profit Margin	15.16%
Profit Margin	9.58%
Free Cash Flow	$4.15M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.12
Inventory Turnover	2.75
Receiveable Turnover	1.15
Days Sales in Receivables	78.59
Return on Equity	-5.05%
Return on Tangible Equity	-4.25%
Return on Assets	1.19%
Return on Investments	-11.31%
Book Value Per Share	$-1.84
Free Cash Flow per Share	$0.51
Operating Cash Flow per Share	$0.52

Data from Zacks Investment Research, Inc.